Mackenzie Financial’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$176M Sell
797,795
-935,966
-54% -$259M 0.18% 100
2026
Q1
$512M Buy
1,733,761
+312,268
+22% +$92.8M 0.61% 34
2025
Q4
$391M Buy
1,421,493
+122,841
+9% +$33.4M 0.46% 51
2025
Q3
$351M Sell
1,298,652
-81,199
-6% -$22.1M 0.43% 55
2025
Q2
$380M Buy
1,379,851
+210,642
+18% +$57.3M 0.49% 51
2025
Q1
$310M Buy
1,169,209
+17,343
+2% +$4.28M 0.44% 60
2024
Q4
$267M Sell
1,151,866
-76,074
-6% -$17.5M 0.36% 70
2024
Q3
$271M Buy
1,227,940
+245,181
+25% +$50.7M 0.38% 74
2024
Q2
$193M Sell
982,759
-127,074
-11% -$26.3M 0.29% 93
2024
Q1
$239M Sell
1,109,833
-130,170
-10% -$27.3M 0.34% 80
2023
Q4
$261M Sell
1,240,003
-21,497
-2% -$4.59M 0.39% 66
2023
Q3
$254M Buy
1,261,500
+11,984
+1% +$2.38M 0.43% 62
2023
Q2
$233M Buy
1,249,516
+445,479
+55% +$82.3M 0.35% 71
2023
Q1
$154M Buy
804,037
+111,334
+16% +$20.1M 0.24% 106
2022
Q4
$116M Buy
692,703
+1,822
+0.3% +$317K 0.19% 122
2022
Q3
$122M Sell
690,881
-125,143
-15% -$24.7M 0.21% 117
2022
Q2
$167M Sell
816,024
-202,794
-20% -$43M 0.27% 92
2022
Q1
$242M Sell
1,018,818
-8,010
-0.8% -$1.88M 0.32% 74
2021
Q4
$235M Sell
1,026,828
-216,223
-17% -$47.6M 0.32% 79
2021
Q3
$240M Sell
1,243,051
-2,109
-0.2% -$427K 0.34% 72
2021
Q2
$265M Sell
1,245,160
-37,492
-3% -$7.92M 0.37% 72
2021
Q1
$262M Buy
1,282,652
+382,096
+42% +$75.3M 0.4% 64
2020
Q4
$164M Buy
900,556
+19,815
+2% +$3.37M 0.35% 89
2020
Q3
$147M Sell
880,741
-10,714
-1% -$1.8M 0.37% 85
2020
Q2
$145M Buy
891,455
+123,562
+16% +$22.1M 0.39% 75
2020
Q1
$133M Buy
767,893
+157,913
+26% +$31.4M 0.43% 59
2019
Q4
$122M Sell
609,980
-92,440
-13% -$19M 0.3% 88
2019
Q3
$148M Sell
702,420
-62,452
-8% -$13M 0.39% 66
2019
Q2
$148M Sell
764,872
-293,613
-28% -$54.1M 0.38% 69
2019
Q1
$174M Buy
1,058,485
+132,403
+14% +$23.4M 0.42% 65
2018
Q4
$174M Buy
926,082
+221,658
+31% +$40.9M 0.46% 58
2018
Q3
$120M Buy
704,424
+97,082
+16% +$16.3M 0.29% 94
2018
Q2
$99.6M Buy
607,342
+12,015
+2% +$1.96M 0.25% 97
2018
Q1
$96.3M Buy
595,327
+148,150
+33% +$23.6M 0.25% 89
2017
Q4
$65.3M Buy
447,177
+145,283
+48% +$20.7M 0.16% 131
2017
Q3
$41M Sell
301,894
-41,178
-12% -$5.2M 0.22% 122
2017
Q2
$43M Sell
343,072
-33,695
-9% -$4.03M 0.24% 112
2017
Q1
$44.8M Sell
376,767
-27,795
-7% -$3.34M 0.26% 105
2016
Q4
$46.7M Buy
404,562
+141,975
+54% +$15.8M 0.28% 97
2016
Q3
$27.4M Buy
262,587
+12,033
+5% +$1.26M 0.17% 140
2016
Q2
$24.4M Buy
250,554
+4,115
+2% +$389K 0.14% 170
2016
Q1
$23.7M Buy
246,439
+8,493
+4% +$773K 0.21% 119
2015
Q4
$21.6M Buy
237,946
+1,760
+0.7% +$166K 0.13% 158
2015
Q3
$21.9M Sell
236,186
-11,192
-5% -$1.06M 0.13% 161
2015
Q2
$23M Buy
247,378
+769
+0.3% +$71.7K 0.12% 172
2015
Q1
$23.4M Sell
246,609
-53,791
-18% -$4.98M 0.12% 169
2014
Q4
$26.6M Sell
300,400
-39,007
-11% -$3.31M 0.14% 149
2014
Q3
$27.1M Buy
339,407
+184,236
+119% +$13.9M 0.14% 145
2014
Q2
$11M Buy
155,171
+8,771
+6% +$617K 0.05% 254
2014
Q1
$10.8M Buy
146,400
+38,700
+36% +$2.92M 0.05% 242
2013
Q4
$8.45M Buy
+107,700
New +$8.43M 0.04% 255

Other funds holding CME

Mackenzie Financial's CME Position: Q2 2026 in Review

Mackenzie Financial reduced its CME Group (CME) stake by 54% in Q2 2026, selling an estimated $259M and leaving 797,795 shares worth $176M. The position accounts for 0.18% of the portfolio, ranked #100.

Mackenzie Financial first reported a position in CME in Q4 2013 and has held it in 51 quarters since. The position peaked at $512M in Q1 2026. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Mackenzie Financial held 797,795 shares of CME Group worth $176M as of Q2 2026.
  • Mackenzie Financial sold 935,966 CME Group shares in Q2 2026, an estimated $259M.
  • CME Group made up 0.18% of Mackenzie Financial's portfolio in Q2 2026, its #100 holding.
  • Mackenzie Financial first reported a position in CME Group in Q4 2013 and has held it in 51 quarters since.
  • Mackenzie Financial's CME Group position peaked at $512M in Q1 2026.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.